These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 8103763

  • 21. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G, Amplaz S, Benvenuti S, Bertozzo A.
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract] [Full Text] [Related]

  • 22. Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.
    Welage LS, Dunn-Kucharski VA, Berardi RR, Shea MJ, Dechert RE, Bleske BE.
    Pharmacotherapy; 1995; 15(2):158-63. PubMed ID: 7624262
    [Abstract] [Full Text] [Related]

  • 23. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
    Kapoor S, Pal S, Sahni P, Dattagupta S, Kanti Chattopadhyay T.
    J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879
    [Abstract] [Full Text] [Related]

  • 24. [Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].
    Paleev NR, Isakov VA, Ivanova OV.
    Klin Med (Mosk); 2005 Dec; 83(1):9-14. PubMed ID: 15759483
    [No Abstract] [Full Text] [Related]

  • 25. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
    Adachi K, Komazawa Y, Mihara T, Azumi T, Fujisawa T, Katsube T, Furuta K, Kinoshita Y.
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
    [Abstract] [Full Text] [Related]

  • 26. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 27. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
    Maculotti L, Pradella P.
    Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
    [Abstract] [Full Text] [Related]

  • 28. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
    Mason I, Millar LJ, Sheikh RR, Evans WM, Todd PL, Turbitt ML, Taylor MD.
    Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
    [Abstract] [Full Text] [Related]

  • 29. No significant difference in neutrophil activation found among three H2RAs.
    Fukuda M, Shirasaka D, Aoyama N, Miki I, Kachi M, Morita Y, Tamura T, Kasuga M.
    Dig Liver Dis; 2007 Feb; 39(2):130-5. PubMed ID: 17161670
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
    Lin CJ, Huang CL, Hsu HW, Chen TL.
    Acta Anaesthesiol Sin; 1996 Dec; 34(4):179-84. PubMed ID: 9084544
    [Abstract] [Full Text] [Related]

  • 33. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
    Segal R, Russell WL, Oh T, Ben-Joseph R.
    Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052
    [Abstract] [Full Text] [Related]

  • 34. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R, Howard JM, Maton PN, Wank SA, Slaff JI, Gardner JD, Jensen RT.
    Am J Med; 1986 Oct 24; 81(4B):49-59. PubMed ID: 2877575
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN, Gardner JD, Jensen RT.
    Gastroenterol Clin North Am; 1989 Dec 24; 18(4):847-63. PubMed ID: 2575602
    [Abstract] [Full Text] [Related]

  • 37. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K, Lin HJ, Perng CL, Tseng GY, Yu KW, Chang FY, Lee SD.
    Hepatogastroenterology; 2004 Dec 24; 51(59):1540-3. PubMed ID: 15362796
    [Abstract] [Full Text] [Related]

  • 38. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
    Shimokawa M, Yamamoto K, Kawakami J, Sawada Y, Iga T.
    Toxicol Appl Pharmacol; 1996 Feb 24; 136(2):317-23. PubMed ID: 8619239
    [Abstract] [Full Text] [Related]

  • 39. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
    Mohamed SA, al Karawi MA.
    Hepatogastroenterology; 1996 Feb 24; 43(10):863-5. PubMed ID: 8884305
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.